Prot #CBI-2018-DDCM: Development and Validation of a Gene Expression Assay to Provide an Objective Differential Diagnostic Result of Ambiguous (Difficult-to-Diagnose) Melanocytic Lesions

Project: Research project

Project Details

StatusActive
Effective start/end date2/3/202/3/23

Funding

  • Castle Biosciences, Inc. (Prot #CBI-2018-DDCM)